2016~2018年成都市六家医疗机构呼吸系统药物调查分析

Investigation and analysis of the utilization of respiratory system drugs in 6 medical institutions during 2016~2018

目的了解医疗机构呼吸系统药物使用情况,为呼吸系统药物的合理应用提供依据。方法采用回顾性分析方法,统计出2016年~2018年成都市六所医疗机构呼吸系统用药情况,根据ATC分类法将呼吸系统用药分为平喘药、祛痰药和镇咳药三类,采用药物利用研究方法进行分析。结果呼吸系统药物三年来采购总品种数趋于平稳,而采购金额呈上升趋势,其中平喘药的品种数和采购金额占比一直稳居第一位。吸入用布地奈德混悬液采购金额3年稳居第一。孟鲁司特钠片的DDDs排名由2016年的第17名上升为2018年的第2名。注射用多索茶碱、盐酸溴已新葡萄糖注射液和痰热清注射液等的DDC都有明显下降。结论通过"新医改"政策的实施,大多数药品的DDC都呈现逐年下降的趋势。吸入用布地奈德混悬液和孟鲁司特钠片的使用频率持续升高,各医院使用这两种药物时需引起重视,避免不合理使用。

Objective To understand the utilization of respiratory system drugs in medical institutions to provide reference for rational use of the drugs.Methods Respiratory system medication from 2016 to 2018 in 6 medical institutions of Chengdu area was retrospectively investigated.According to ATC classification,the respiratory system drugs were divided into three categories:antiasthmatic,expectorant and cough medicine.They were analyzed by using drug utilization method.Results During the three years,the total number of respiratory drugs purchased was stable,but the purchase amount was increased.Among them,the number of varieties of antiasthmatic drugs and the proportion of purchase amount always occupied the first place.The purchase amount of the budesonide suspension for inhalation was the first place and showed an increasing tendency.The DDDs of montelukast sodium tablets rose from the 17 th in 2016 to the 2 nd position in 2018.The DDC of doxofylline injection,bromhexine hydrochloride and glucose injection and tanreqing injection were decreased obviously.Conclusion Through the implementation of the new medical reform,the DDC of most drugs are decreased gradually.However,the use of budesonide suspension for inhalation and montelukast sodium tablets should be paid more attention to avoid overusing.